. 1981 Apr;41(4):1257-62.

Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system

E A Rorke et al. Cancer Res. 1981 Apr.

. 1981 Apr;41(4):1257-62.

No abstract available

Similar articles

Biological potency and uterine estrogen receptor interactions of the metabolites of the antiestrogens CI628 and U23,469.
Hayes JR, Rorke EA, Robertson DW, Katzenellenbogen BS, Katzenellenbogen JA. Hayes JR, et al. Endocrinology. 1981 Jan;108(1):164-72. doi: 10.1210/endo-108-1-164. Endocrinology. 1981. PMID: 7007017 No abstract available.
Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
Tsai TL, Katzenellenbogen BS. Tsai TL, et al. Cancer Res. 1977 May;37(5):1537-43. Cancer Res. 1977. PMID: 404032
Androgen effects mediated by estrogen receptor in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Garcia M, Rochefort H. Garcia M, et al. Cancer Res. 1978 Nov;38(11 Pt 1):3922-9. Cancer Res. 1978. PMID: 100211 No abstract available.
Laboratory models of breast cancer to aid the elucidation of antiestrogen action.
Jordan VC. Jordan VC. J Lab Clin Med. 1987 Mar;109(3):267-77. J Lab Clin Med. 1987. PMID: 3102656 Review.
Anti-oestrogen action in experimental breast cancer.
Jordan VC, Naylor KE, Dix CJ, Prestwich G. Jordan VC, et al. Recent Results Cancer Res. 1980;71:30-44. doi: 10.1007/978-3-642-81406-8_8. Recent Results Cancer Res. 1980. PMID: 6768113 Review. No abstract available.